Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease.
Arnold R, Massenkeil G, Bornhäuser M, Ehninger G, Beelen DW, Fauser AA, Hegenbart U, Hertenstein B, Ho AD, Knauf W, Kolb HJ, Kolbe K, Sayer HG, Schwerdtfeger R, Wandt H, Hoelzer D.
Arnold R, et al. Among authors: knauf w.
Leukemia. 2002 Dec;16(12):2423-8. doi: 10.1038/sj.leu.2402712.
Leukemia. 2002.
PMID: 12454748
Clinical Trial.